BERLIN (Reuters) - Victims of thalidomide said on Saturday an apology from the German inventor of the drug that caused birth defects in thousands of babies around the world was too little too late.

LONDON (Reuters) - Half a century after the launch of the notorious morning sickness pill thalidomide, its surviving victims are demanding 4 billion euros ($6.3 billion) in compensation from the ...

It was a grim harvest for West Germany: 3,000 babies dead shortly after birth and another 3,000 with grotesque malformations, because their mothers had taken the sleeping-pill tranquilizer thalidomide ...

VICTIMS of thalidomide won an $89m settlement, but their lawyers say the drug's manufacturer behaved appallingly in not paying compensation. More than 100 Australian and New Zealand victims, many of ...

Thalidomide was originally marketed in several countries as a morning sickness drug by Chemie Grünenthal in the late 1950s and early 1960s until its use was linked to thousands of deaths and birth ...

More than five decades on, the battle for justice over birth defects caused by the drug thalidomide continues in only one European country: Spain. Spanish victims of thalidomide are the only ones ...

Diageo P.L.C. will pay $99 million New Zealand ($80.4 million) to settle claims from victims of a drug that resulted in birth defects, TVNZ reported. The drug, thalidomide, was taken off the market in ...

In 2014 Digital Journal reported on the plight of those blighted by the Thalidomide scandal in Canada. More than 50 years after the drug, Thalidomide, was prescribed as a morning sickness treatment ...

MELBOURNE, Australia (Reuters)—An Australian woman has won a multimillion-dollar payout from U.K. company Diageo P.L.C., the local distributor of the drug thalidomide that caused birth defects in ...

Just under a year ago, Jacqui Browne stated her grim certainty. That certainty was that the Government was simply waiting for Irish Thalidomide survivors to die. This week she died, her death not ...

This year marked two important anniversaries in the regulatory community. In the US, regulators noted the 50 th anniversary of the passage of the Kefauver-Harris Amendments to the Federal Food, Drug ...